Cerebral Autoregulation Assessment Using the Near Infrared Spectroscopy 'NIRS-Only' High Frequency Methodology in Critically Ill Patients: A Prospective Cross-Sectional Study.

capillary transit time cerebral autoregulation deoxyhemoglobin near infrared spectroscopy oxyhemoglobin transfer function analysis

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
21 07 2022
Historique:
received: 09 06 2022
revised: 13 07 2022
accepted: 17 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 29 7 2022
Statut: epublish

Résumé

Impairments in cerebral autoregulation (CA) are related to poor clinical outcome. Near infrared spectroscopy (NIRS) is a non-invasive technique applied to estimate CA. Our general purpose was to study the clinical feasibility of a previously published 'NIRS-only' CA methodology in a critically ill intensive care unit (ICU) population and determine its relationship with clinical outcome. Bilateral NIRS measurements were performed for 1-2 h. Data segments of ten-minutes were used to calculate transfer function analyses (TFA) CA estimates between high frequency oxyhemoglobin (oxyHb) and deoxyhemoglobin (deoxyHb) signals. The phase shift was corrected for serial time shifts. Criteria were defined to select TFA phase plot segments (segments) with 'high-pass filter' characteristics. In 54 patients, 490 out of 729 segments were automatically selected (67%). In 34 primary neurology patients the median (q1-q3) low frequency (LF) phase shift was higher in 19 survivors compared to 15 non-survivors (13° (6.3-35) versus 0.83° (-2.8-13),

Identifiants

pubmed: 35883697
pii: cells11142254
doi: 10.3390/cells11142254
pmc: PMC9317651
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Biomed Opt. 2005 Jul-Aug;10(4):44003
pubmed: 16178637
J Neurotrauma. 2021 Oct 15;38(20):2790-2800
pubmed: 34407385
Curr Opin Crit Care. 2022 Apr 1;28(2):123-129
pubmed: 35058408
J Appl Physiol (1985). 2009 Jan;106(1):153-60
pubmed: 18974368
Neurol Res. 1999 Oct;21(7):665-9
pubmed: 10555189
Med Eng Phys. 2014 May;36(5):638-45
pubmed: 24703503
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Crit Care. 2012 Oct 04;16(5):R181
pubmed: 23036135
Physiol Rev. 2021 Oct 1;101(4):1487-1559
pubmed: 33769101
J Cereb Blood Flow Metab. 2016 Apr;36(4):665-80
pubmed: 26782760
Front Neurol. 2021 Sep 10;12:695705
pubmed: 34566840
J Cereb Blood Flow Metab. 2019 Dec;39(12):2512-2520
pubmed: 30295556
Resuscitation. 2015 May;90:121-6
pubmed: 25769511
PLoS One. 2020 Jan 10;15(1):e0227651
pubmed: 31923919
J Neurosurg. 2001 Sep;95(3):393-401
pubmed: 11565859
Crit Care Med. 2013 Feb;41(2):464-71
pubmed: 23263580
Eur J Appl Physiol. 2021 Aug;121(8):2165-2176
pubmed: 33860383
Neurocrit Care. 2022 Feb;36(1):21-29
pubmed: 34403122
J Clin Neurosci. 2005 Aug;12(6):643-6
pubmed: 16098757
J Cereb Blood Flow Metab. 2020 Jan;40(1):135-149
pubmed: 30353763
Pediatr Res. 1996 May;39(5):889-94
pubmed: 8726247
J Cereb Blood Flow Metab. 2008 Jun;28(6):1071-85
pubmed: 18349877
Neurosurgery. 1997 Jul;41(1):11-7; discussion 17-9
pubmed: 9218290
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
J Neurotrauma. 2017 Nov 15;34(22):3070-3080
pubmed: 28571485

Auteurs

Jeanette Tas (J)

Department of Intensive Care Medicine, Maastricht University Medical Center+, University Maastricht, 6229 HX Maastricht, The Netherlands.
School for Mental Health and Neuroscience (MHeNS), University Maastricht, 6229 HX Maastricht, The Netherlands.

Nick Eleveld (N)

Department of Neurology and Clinical Neurophysiology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.

Melisa Borg (M)

Department of Intensive Care Medicine, Maastricht University Medical Center+, University Maastricht, 6229 HX Maastricht, The Netherlands.

Kirsten D J Bos (KDJ)

Department of Intensive Care Medicine, Maastricht University Medical Center+, University Maastricht, 6229 HX Maastricht, The Netherlands.

Anne P Langermans (AP)

Department of Intensive Care Medicine, Maastricht University Medical Center+, University Maastricht, 6229 HX Maastricht, The Netherlands.

Sander M J van Kuijk (SMJ)

Department of Clinical Epidemiology and Medical Technology Assessment, (KEMTA), Maastricht University Medical Center+, 6229 HX Maastricht, The Netherlands.

Iwan C C van der Horst (ICC)

Department of Intensive Care Medicine, Maastricht University Medical Center+, University Maastricht, 6229 HX Maastricht, The Netherlands.
Cardiovascular Research Institute Maastricht (CARIM), 6229 HX Maastricht, The Netherlands.

Jan Willem J Elting (JWJ)

Department of Neurology and Clinical Neurophysiology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.

Marcel J H Aries (MJH)

Department of Intensive Care Medicine, Maastricht University Medical Center+, University Maastricht, 6229 HX Maastricht, The Netherlands.
School for Mental Health and Neuroscience (MHeNS), University Maastricht, 6229 HX Maastricht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH